Valneva Operating Margin from 2010 to 2025
| VALN Stock | USD 7.36 0.05 0.67% |
Check Valneva SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Valneva SE's main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.2 M, Interest Expense of 28.2 M or Total Revenue of 92.2 M, as well as many indicators such as Price To Sales Ratio of 4.66, Dividend Yield of 0.0 or PTB Ratio of 6.31. Valneva financial statements analysis is a perfect complement when working with Valneva SE Valuation or Volatility modules.
Valneva | Operating Margin |
Latest Valneva SE's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Valneva SE ADR over the last few years. It is Valneva SE's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Valneva SE's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.27) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Valneva Operating Margin Regression Statistics
| Arithmetic Mean | (0.57) | |
| Geometric Mean | 0.30 | |
| Coefficient Of Variation | (152.70) | |
| Mean Deviation | 0.42 | |
| Median | (0.45) | |
| Standard Deviation | 0.87 | |
| Sample Variance | 0.76 | |
| Range | 3.7957 | |
| R-Value | 0.33 | |
| Mean Square Error | 0.73 | |
| R-Squared | 0.11 | |
| Significance | 0.21 | |
| Slope | 0.06 | |
| Total Sum of Squares | 11.46 |
Valneva Operating Margin History
About Valneva SE Financial Statements
Valneva SE investors utilize fundamental indicators, such as Operating Margin, to predict how Valneva Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on NASDAQ Exchange in the United States.
Check out the analysis of Valneva SE Correlation against competitors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.12) | Revenue Per Share | Quarterly Revenue Growth 0.204 | Return On Assets | Return On Equity |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.